Skip to Main Content (Press Enter)

Logo UNIPV
  • ×
  • Home
  • Corsi
  • Insegnamenti
  • Professioni
  • Persone
  • Pubblicazioni
  • Strutture

UNIFIND
Logo UNIPV

|

UNIFIND

unipv.it
  • ×
  • Home
  • Corsi
  • Insegnamenti
  • Professioni
  • Persone
  • Pubblicazioni
  • Strutture
  1. Pubblicazioni

LEUKEMIA & LYMPHOMA

Rivista
Codice:
E101086
ISSN:
1042-8194
  • Dati Generali

Dati Generali

Pubblicazioni (42)

  • ascendente
  • decrescente
A Phase II study of Bendamustine in Combination With Rituximab as Initial Treatment for Patients With Indolent non-follicular non-Hodgkin's Lymphoma
Articolo
A nationwide prospective registry of bortezomib-based therapy in light chain (AL) amyloidosis
Articolo
Acute megakaryoblastic leukemia with a novel GATA1 mutation in a second trimester stillborn fetus with trisomy 21
Articolo
Acute promyelocitic leukemia toluidine blue subtype.
Articolo
Alternative Splicing of hTERT: a further Mechanism for the Control of Active hTERT in Acute Myeloid Leukaemia
Articolo
Alternative options for elderly patients with limited stage diffuse large B-cell lymphoma: R-chemotherapy vs. R-chemotherapy plus radiotherapy
Articolo
Bortezomib plus dexamethasone can improve stem cell collection and overcome the need for additional chemotherapy before autologous transplant in patients with myeloma.
Articolo
Clues to pathogenesis of Waldenström macroglobulinemia and immunoglobulin M monoclonal gammopathy of undetermined significance provided by analysis of immunoglobulin heavy chain gene rearrangement and clustering of B-cell receptors
Articolo
Corneal sub-basal neural damage pattern in multiple myeloma patients treated with bortezomib: An in vivo confocal study
Articolo
Early stage gastric diffuse large B-cell lymphomas: Results of a randomised trial comparing chemotherapy alone versus chemotherapy + involved field radiotherapy
Articolo
Efficacy and safety of intrathecal liposomal cytarabine for the treatment of meningeal relapse in acute lymphoblastic leukemia: experience of two pediatric institutions
Articolo
Expression of p53, Bcl-2 and ras oncoproteins and apoptosis levels in acute leukaemias and myelodysplastic syndromes.
Articolo
Genomic aberrations affecting the outcome of immunodeficiency-related diffuse large B-cell lymphoma.
Articolo
Growth factors in the therapy of myelodisplasia: biological aspects.
Articolo
HLA typing and VH gene rearrangement analysis in a family with hairy cell leukaemia
Articolo
Interim PET and clinical outcome in early stage Hodgkin’s Lymphoma patients treated with combined modality therapy
Articolo
Long term results of interferon treatment in hairy cell leukemia. Italian Cooperative Group of Hairy Cell Leukemia (ICGHCL).
Articolo
Long-term control of extensive refractory chronic graft versus host disease in a multiple myeloma relapsing after allogeneic transplant. A case report
Articolo
Long-term outcome of patients with localized aggressive non-Hodgkin lymphoma treated with ProMECE-CytaBOM plus involved-field radiation therapy: a study of the Gruppo Italiano Studio Linfomi.
Articolo
Long-term results of the AIEOP MH’96 childhood Hodgkin’s lymphoma trial and focus on significance of response to chemotherapy and its implication in low risk patients to avoid radiotherapy
Articolo
Mitoxantrone with intremediate- or high-dose Ara-c for refractory acute lymphoblastic leukemia and non-Hodgkin’s lymphoma
Articolo
Nodular lymphocyte predominance Hodgkin's disease: long-term observation reveals a continuous pattern of recurrence.
Articolo
Non-radiolabelled PCR consensus primers and automatic sequencing enable rapid identification of tumor-specific V(H) CDR3 in aggressive B-cell malignancies.
Articolo
Pamidronate versus observation in asymptomatic myeloma: final results with long follow-up of a randomized study
Articolo
Primary mediastinal B-cell lymphoma: update of its clinicopathologic features.
Articolo
R-CHOP vs. R-mini-CEOP for the initial treatment of elderly “fit” patients with diffuse large B-cell lymphoma. Results from the ANZINTER3 trial of the Intergruppo Italiano Linfomi (IIL).
Articolo
Rationale for the clinical application of flow cytometry in patients with myelodysplastic syndromes: position paper of an International Consortium and the European LeukemiaNet Working Group
Articolo
Risk of hepatitis B reactivation under treatment with tyrosine-kinase inhibitors for chronic myeloid leukemia
Articolo
Rituximab and subcutaneous cladribine in chronic lymphocytic leukemia for newly diagnosed and relapsed patients
Articolo
Rituximab with cyclophosphamide, vincristine, non-pegylated liposomal doxorubicin and prednisone as first-line treatment for splenic marginal zone lymphoma: a Fondazione Italiana Linfomi phase II study
Articolo
Role of glutathione-S-transferase (GST) polymorphisms in patients with advanced Hodgkin lymphoma: results from the HD2000 GISL trial.
Articolo
Role of the molecular staging and response in the management of follicular lymphoma patients
Articolo
Simplification of risk stratification for splenic marginal zone lymphoma: a point-based score for practical use.
Articolo
Smoldering multiple myeloma: the role of different scoring systems in identifying high-risk patients in real-life practice
Articolo
Survivin expression in acute leukemias and myelodysplastic syndromes.
Articolo
Systematic screening for SARS-CoV-2 in patients with hematological malignancies on active anticancer treatment in the outpatient setting
Articolo
Systemic mastocytosis and lymphoplasmacytic lymphoma: an unusual and intriguing form of SM-AHN
Articolo
TREATMENT OF POLYCYTHEMIA VERA AND ESSENTIAL THROMBOCYTHEMIA: THE ROLE OF PIPOBROMAN.
Articolo
The double significance of idelalisib immune-related toxicity
Articolo
The quest for validated treatment endpoints in light chain (AL) amyloidosis: composite criteria for a composite disease
Articolo
Three cases of primary cutaneous lymphoblastic lymphoma: microarray-based comparative genomic hybridization and gene expression profiling studies with review of literature.
Articolo
Vascular endothelial growth factor overexpression in myelodysplastic syndrome bone marrow cells: biological and clinical implications
Articolo
No Results Found
  • «
  • ‹
  • {pageNumber}
  • ›
  • »
{startItem} - {endItem} di {itemsNumber}
  • Utilizzo dei cookie

Realizzato con VIVO | Designed by Cineca | 26.5.1.0